Couverture de Simon Says

Simon Says

Simon Says

De : Business RadioX ®
Écouter gratuitement

À propos de ce contenu audio

Al Simon of Sandler Training by Simon interviews local business owners and sales professionals about some of the sales challenges they face and things they can do to increase sales for their organizations.© %s Business Radio X Politique et gouvernement
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • SIMON SAYS, LET’S TALK BUSINESS: Chris Lindenau with Fusus
      Mar 23 2023
      Chris Lindenau/Fusus Fusus is the most widely used and trusted real-time crime center platform in U.S. Law Enforcement. The Fusus platform is an open ecosystem that integrates and enhances all public safety and investigations assets. It can integrate with any data source, pull in public and private video feeds, enable video sources with artificial intelligence, […]
      Afficher plus Afficher moins
      Moins d'une minute
    • SIMON SAYS, LET’S TALK BUSINESS: Tim Yoder with Duratec Roofing Solutions and J.C. Laurent with Penon Partners
      Feb 16 2023
      Tim Yoder/Duratec Roofing Solutions Duratec Roofing Solutions is a commercial roofing company specializing in the coatings and restoration industry along with single-plys. Located in Monticello, GA they service all of Georgia and surrounding states. Their goal is to provide service and quality for long lasting customer relationships. Jean-Christophe (J.C.) Laurent/Penon Partners Penon Partners is […]
      Afficher plus Afficher moins
      Moins d'une minute
    • SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax
      Jan 19 2023
      David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s […]
      Afficher plus Afficher moins
      Moins d'une minute
    Aucun commentaire pour le moment